Compare · 2 funds side by side · dividends reinvested

IBRN and ARKG

IBRNiShares×ARKGARK×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$6,586ARKG · best of the two

02 / 04

IBRN and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Neuroscience and Healthcare ETFSectors · Health care0.47%0.96%+3.0%+11.3%+21.0%[…]−26.3%26.7%$7M1.4

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: IBRN 2022 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

iShares Neuroscience and Healthcare ETF · $7M[…]

IBRN

ARKG

ARK Genomic Revolution ETF · $2.2B$6,586

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

IBRNMeasureARKG

+3.0%Year to dateJan 1 → Nov 3+70.9%

+11.3%1 yearTotal return+59.0%

+21.0%3 years · per year$10,000 became $17,703 · $22,262+30.6%

[…]5 years · per year$10,000 became […] · $6,586−8.0%

0.47%Expense ratio$47 · $75 a year on $10k · lower is better0.75%

0.96%Trailing 12-mo yield$96 · $0 a year on $10k0.00%

−26.3%Worst dropSmaller is better−27.5%

26.7%VolatilityLower is calmer45.8%

IBRNARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

4–3IBRN wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IBRN vs ARKG: Top 5 Holdings

Today

IBRN

23.5%in top 5

ARKG

in top 535.4%

IBRNStockARKG

not top 5TEM9.8%

not top 5TXG7.5%

not top 5TWST7.4%

5.6%BIIBnot top 5

not top 5CRSP5.5%

not top 5GH5.1%

4.8%ALKSnot top 5

4.6%NBIXnot top 5

4.4%EWTXnot top 5

4.2%PTCTnot top 5

Held in common0.0%

End-of-day Nov 3, 2026 · share of each fund

IBRN vs ARKG Returns, Every Period

iSharesIBRN

+11.3%

past year

ARKGARK

+59.0%

past year

IBRNARKGFaded: behind in that period

0–3ARKG wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

IBRN vs ARKG

YTD

iSharesIBRN

+3.0%

ARKGARK

+70.9%

+3.0%Year to date+70.9%

−26.3%Worst drop · 1Y−27.5%

26.7%Volatility · 1Y45.8%

1.0%Yield0.0%

$6.6MAssets$2.2B

3–1IBRN wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IBRN, ARKG

Today

0.47%lowest, IBRN

FundExpense ratioFee$10k

IBRN0.47%$47

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: IBRN, ARKG

0.96%highest, IBRN

FundTrailing yieldYield$10k

IBRN0.96%$96

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$49most kept, IBRN

IBRN$96 − $47 = $49

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: IBRN, ARKG

Today

0.0%most shared, IBRN and ARKG

IBRNARKG

IBRN—0.0%

ARKG0.0%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+59.0%ARKG, at 45.8% volatility

IBRNWorst drop−26.3%26.7% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

IBRNARKG

+3.0%Year to date+70.9%

1.0%Yield0.0%

+11.3%Past year+59.0%

0.47%Fee0.75%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026